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ABSTRACT 
BACKGROUND AND OBJECTIVES:  
Obesity has become a major health problem all over the world particularly in 
developed countries, with increasing incidence and prevalence in adults and children. 
Obesity, in particular, excess of visceral adipose tissue, is causally linked with a 
cluster of metabolic risk factors including glucose intolerance, hypertension and 
dyslipidemia that leads to the development of Metabolic Syndrome. Omentin 1, an 
adipokine primarily secreted by visceral adipose tissue, is thought to   play a role in 
the pathophysiology of insulin resistance, inflammation, endothelial dysfunction in 
obesity. The objective of this study was to compare Plasma Omentin 1 level in obese 
individual   with and without   metabolic risk factors and to correlate its level with 
Fasting plasma glucose, Hypertension, Serum Triglycerides and Serum HDL 
Cholesterol. 
MATERIAL AND METHODS:  
This study was conducted at M.G.M. Govt. Hospital attached to K.A.P.V. 
Govt. Medical College, Trichy. Study population was divided into two groups:          
44 obese individuals without any metabolic risk factors as controls and 44   obese 
persons with any one of the following  metabolic risk factors, Fasting Plasma Glucose 
≥ 100 mg/dL, Blood Pressure ≥ 130 mmHg systolic or  ≥ 85 mmHg diastolic, 
Triglycerides ≥ 150 mg/d, or HDL Cholesterol < 40 mg/dL  and < 50 mg/dL for male 
& female respectively  as cases. Plasma Omentin 1 level was measured by using 
ELISA method and compared in both groups. 
 RESULTS : 
Plasma Omentin 1 level was very significantly low in cases when compared to 
controls (p < 0.001). Among the metabolic risk factors of obesity, Plasma omentin 1 
level was significantly decreased in persons with high Systolic or Diastolic BP, 
Impaired Fasting Glucose as  FPG ≥ 100 mg/dl and high serum triglycerides              
(p < 0.05). Plasma Omentin 1 had significant negative correlation with Systolic Blood 
Pressure, Diastolic Blood Pressure and Serum Triglycerides. (p < 0.05). 
CONCLUSION: 
The results of  our study shows that Plasma Omentin 1 level significantly 
decreased in obese individuals with metabolic risk factors  when compared to 
controls. Omentin 1 had a statistically significant negative correlation with systolic 
BP, Diastolic BP and Serum Triglycerides level. Omentin 1 level decreased in persons 
with Impaired Fasting Glucose. Hence, Plasma Omentin 1 can be used as a novel 
biomarker for metabolic risk factors like Impaired Fasting Glucose, Hypertension and 
Dyslipidemia in obesity. 
 
Key words: Omentin 1; Adipokine; Obesity; Metabolic Syndrome;  
Insulin Resistance; Hypertension;  Dyslipidemia. 
 
 
